37662-3837 : Lilium Stargazer 500 [Hp_c]/1 Oral Pellet
| NDC: | 37662-3837 |
| Labeler: | Hahnemann Laboratories, Inc. |
| Product Type: | Human OTC Drug |
| Drug Name: | Lilium Stargazer |
| Dosage Form: | Oral Pellet |
| Rev. Date: |
NDC Package Codes:
- 37662-3837-1: 200 PELLET IN 1 VIAL, GLASS (37662‑3837‑1)
- 37662-3837-2: 500 PELLET IN 1 VIAL, GLASS (37662‑3837‑2)
- 37662-3837-3: 3000 PELLET IN 1 BOTTLE, GLASS (37662‑3837‑3)
- 37662-3837-4: 10000 PELLET IN 1 BOTTLE, GLASS (37662‑3837‑4)
Active Ingredients:
- Lilium Longiflorum Bulb
Dosage Strength:
- 500 [hp_C]/1
Related Products:
Based on records with the same trade name.- 37662-3832 Lilium Stargazer 6 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-3833 Lilium Stargazer 12 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-3834 Lilium Stargazer 30 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-3835 Lilium Stargazer 100 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-3836 Lilium Stargazer 200 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-3838 Lilium Stargazer 1 [Hp_m]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-3839 Lilium Stargazer 1 [Hp_q]/1 Oral Pellet by Hahnemann Laboratories, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 37662-3836Next: 37662-3838 >
Related Discussions:
Do zonacin is helpful for narrowing bulbar urethra ethra
Im suffering from recurrent Uti doctor dignosed as suspicious narrowing in Bulbar Urethra adv to take zanocin 200 twice ... 1 reply
Im suffering from recurrent Uti doctor dignosed as suspicious narrowing in Bulbar Urethra adv to take zanocin 200 twice ... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
